Status:
UNKNOWN
Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients
Lead Sponsor:
Eastern Virginia Medical School
Collaborating Sponsors:
Abbott RDx Cardiometabolic
Conditions:
Kidney Failure, Chronic
Heart Failure, Congestive
Eligibility:
All Genders
18-85 years
Brief Summary
Beta Natriuretic Peptide (BNP) is regarded as the most sensitive test for congestive heart failure (CHF). BNP has also been found to be highly predictive of other conditions including pulmonary hypert...
Detailed Description
Plasma BNP is regarded as the most sensitive test for congestive heart failure (CHF). Multiple studies have shown that BNP is a distress hormone released by the distended left ventricular myocardium w...
Eligibility Criteria
Inclusion
- All patients who complete dialysis, are 18 years or older or 85 years or less, and give informed consent will be eligible.
Exclusion
- Inability to provide informed consent
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT00416013
Start Date
December 1 2005
End Date
December 1 2010
Last Update
October 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastern Virginia Medical School
Norfolk, Virginia, United States, 23508